v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating Costs and Expenses:    
General and administrative $ 1,449 $ 1,933
Research and development 2,968 3,459
Total Operating Costs and Expenses 4,417 5,392
Loss from Operations (4,417) (5,392)
Other Income:    
Foreign currency exchange (loss) gain (3) (1)
Interest income 96 228
Total Other Income 93 227
Net Loss before income taxes (4,324) (5,165)
Net Loss Attributable to Common Stockholders $ (4,324) $ (5,165)
Net Loss Per Share - Basic (in dollars per share) $ (1.55) $ (7.53)
Net Loss Per Share - Dilutive (in dollars per share) $ (1.55) $ (7.53)
Weighted average number of shares outstanding during the period - Basic (in shares) 2,782,449 685,923
Weighted average number of shares outstanding during the period - dilutive (in shares) 2,782,449 685,923
Net Loss $ (4,324) $ (5,165)
Gain (loss) on foreign currency translation 654 (569)
Total comprehensive loss $ (3,670) $ (5,734)